About Crystal Biosciences
Crystal Biosciences is a Healthcare company based in Emeryville (United States) founded in 2008, and was acquired by Ligand Pharmaceuticals in October 2017. Specialty company developing antibodies. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Crystal Bioscience is an antibody discovery company. It provides panels of antibodies that have cross-species reactivity, abolishing the need to develop surrogate antibodies for use in pre-clinical studies. Technologies include crystal antibody, single b-cell screening, hu-mAb chicken, and in vivo molecular evolution
- Headquarters Emeryville, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website crystalbioscience.com
- Acquired by Ligand Pharmaceuticals (Oct 2017)
- Latest Funding Round$216.9K (USD), Grant
Aug 2016
- InvestorsHHS
& 1 more
- Acquired byLigand Pharmaceuticals
(Oct 2017)
Funding Insights of Crystal Biosciences
- Total Rounds 5
- Last Round Grant — $216,897
- First Round $172,499
(Dec 2009)
- Investors Count 1
All 5 funding rounds of Crystal Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Crystal Biosciences
Crystal Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Ligand Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Pharmaceutical drugs are manufactured and developed in the United States. | 1987 | ligand.com | San Diego, United States |
Investor details for Crystal Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Crystal Biosciences
4 dated milestones of Crystal Biosciences across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Crystal Biosciences is founded.
- Funding First funding round of $172K.
- Funding Latest funding round, Grant, of $217K.
- Exit Acquired by Ligand Pharmaceuticals.
Competitors of Crystal Biosciences
Crystal Biosciences has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of Crystal Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Crystal Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Crystal Biosciences
Crystal Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Crystal Biosciences is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Crystal Bioscience is an antibody discovery company. It provides panels of antibodies that have cross-species reactivity, abolishing the need to develop surrogate antibodies for use in pre-clinical studies. Technologies include crystal antibody, single b-cell screening, hu-mAb chicken, and in vivo molecular evolution.
Crystal Biosciences's top competitors include GenScript, Epitomics and Vector Laboratories.
Crystal Biosciences has 2 investors. Key investors include HHS, and Ligand Pharmaceuticals.
Yes. Crystal Biosciences was acquired by Ligand Pharmaceuticals in October 2017.